Molecular Templates, Inc. financial data

Symbol
MTEM on Nasdaq
Industry
Pharmaceutical Preparations
Location
9301 Amberglen Blvd, Suite 100, Austin, TX
State of incorporation
DE
Fiscal year end
December 31
Former names
THRESHOLD PHARMACEUTICALS INC (to 8/1/2017)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 113 % -15.4%
Debt-to-equity 455 %
Return On Equity -164 % -52.4%
Return On Assets -48.5 % -3.94%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.58M shares -91.8%
Common Stock, Shares, Outstanding 6.58M shares -88.3%
Entity Public Float 18M USD -38.7%
Common Stock, Value, Issued 7K USD -87.5%
Weighted Average Number of Shares Outstanding, Basic 6.56M shares +74.5%
Weighted Average Number of Shares Outstanding, Diluted 6.56M shares +74.5%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 29.2M USD -59.4%
General and Administrative Expense 15.1M USD -34.4%
Operating Income (Loss) -18.9M USD +57.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -8.14M USD +91.2%
Income Tax Expense (Benefit) 26K USD
Net Income (Loss) Attributable to Parent 10.8M USD
Earnings Per Share, Basic -0.68 USD/shares +97.2%
Earnings Per Share, Diluted -0.65 USD/shares +97.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.66M USD +95%
Marketable Securities, Current 2.89M USD -97.2%
Cash, Cash Equivalents, and Short-term Investments 41.7M USD -66.5%
Other Assets, Current 777K USD -71.3%
Assets, Current 12M USD +1.63%
Property, Plant and Equipment, Net 5.24M USD -48.4%
Operating Lease, Right-of-Use Asset 8.12M USD -20.1%
Other Assets, Noncurrent 1.32M USD -60.8%
Assets 26.7M USD -24.8%
Accounts Payable, Current 2.77M USD -40.6%
Employee-related Liabilities, Current 43K USD +153%
Accrued Liabilities, Current 2.27M USD -35.3%
Liabilities, Current 7.68M USD -71.5%
Operating Lease, Liability, Noncurrent 8.39M USD -23.9%
Other Liabilities, Noncurrent 1.47M USD +8.6%
Liabilities 19.6M USD -55.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1K USD
Retained Earnings (Accumulated Deficit) -460M USD -3.51%
Stockholders' Equity Attributable to Parent 7.11M USD
Liabilities and Equity 26.7M USD -24.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.24M USD +72.9%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 26M USD +21.9%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 6.58M shares -88.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -5.24M USD -180%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.11M USD +47.5%
Deferred Tax Assets, Valuation Allowance 112M USD -2.03%
Deferred Tax Assets, Gross 116M USD -3.15%
Operating Lease, Liability 11M USD -17.6%
Depreciation 4.8M USD -40%
Payments to Acquire Property, Plant, and Equipment 183K USD -66.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -15.6M USD +66.3%
Lessee, Operating Lease, Liability, to be Paid 13.1M USD -20.3%
Property, Plant and Equipment, Gross 34.4M USD -1.16%
Operating Lease, Liability, Current 2.64M USD +12.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.56M USD -22.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.3M USD -2.08%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.05M USD -32.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.64M USD +2.81%
Deferred Tax Assets, Operating Loss Carryforwards 58.8M USD +9.06%
Preferred Stock, Shares Issued 250 shares 0%
Preferred Stock, Shares Authorized 2M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.15M USD -18.5%
Operating Lease, Payments 834K USD +3.47%
Additional Paid in Capital 468M USD +7.22%
Preferred Stock, Shares Outstanding 250 shares 0%
Depreciation, Depletion and Amortization 1.12M USD -41.8%
Share-based Payment Arrangement, Expense 4.42M USD -52.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%